Join to View Full Profile
9400 Campus Point DrLa Jolla, CA 92037
Phone+1 858-249-3249
Dr. Yeung is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kay Yeung is an oncologist based in La Jolla, CA, specializing in breast cancer. She completed her fellowship in Hematology and Medical Oncology at the University of California (San Diego) Medical Center and her residency in Internal Medicine at the same institution. Dr. Yeung is currently an Associate Professor at UC San Diego Health at The Rebecca and John Moores UCSD Cancer Center and the Komen Comprehensive Breast Health Center. She leads multiple breast cancer clinical trials and translational research. She is also a mentor for multiple trainees ranging from medical school students to fellows and junior faculty.
Education & Training
University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 2015 - 2017- University of California (San Diego) Medical CenterResidency, Internal Medicine, 2012 - 2014
New York University School of MedicineClass of 2012
Certifications & Licensure
CA State Medical License 2013 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Dose-escalation Study of the Safety and Pharmacology of DAN-222 in Subjects With Metastatic Breast Cancer Start of enrollment: 2022 Feb 02
- A Study of Zanidatamab (ZW25) With Evorpacept (ALX148) in Patients With Advanced HER2-expressing Cancer Start of enrollment: 2021 Sep 15
- A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer Start of enrollment: 2022 Mar 07
Publications & Presentations
PubMed
- The Hallmarks of Predictive Oncology.Akshat Singhal, Xiaoyu Zhao, Patrick Wall, Emily So, Guido Calderini
Cancer Discovery. 2025-02-07 - 4 citationsDatopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.Katia Khoury, Jane L Meisel, Christina Yau, Hope S Rugo, Rita Nanda
Nature Medicine. 2024-12-01 - 12 citationsDatopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.Rebecca A Shatsky, Meghna S Trivedi, Christina Yau, Rita Nanda, Hope S Rugo
Nature Medicine. 2024-12-01
Grant Support
- Breast Cancer Research Program Breakthrough Fellowship AwardDepartment of Defense2017–2020
Professional Memberships
- Member
- Member
Other Languages
- Chinese (Cantonese), Chinese (Mandarin)
External Links
- UC San Diego Health Provider Profilehttps://providers.ucsd.edu/details/32947/kay-yeung-cancer-la_jolla
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
